Orolingual Angioedema During Thrombolysis in Acute Ischemic Stroke: A Case Report

Overview

Journal World J Emerg Med

Specialty Emergency Medicine

Date 2022 Jan 10

PMID 35003421

Authors

Yao Wang

Hao Sun

Gan-Nan Wang

Xiao-Min Zhang

Jin-Song Zhang

Affiliations

Soon will be listed here.

Citing Articles

Risk of angioedema and thrombolytic therapy among stroke patients: An analysis of data from the FDA Adverse Event Reporting System database.

Xiang H, Ma Y, Luo X, Guo J, Yao M, Liu Y Neurotherapeutics. 2024; 22(1):e00474.

PMID: 39482180 PMC: 11742624. DOI: 10.1016/j.neurot.2024.e00474.

Application of multidisciplinary simulation training in the treatment of acute ischemic stroke: a quality improvement project.

Huang G, Yang H, Yao H, Fan X, Xia W, Xu Y World J Emerg Med. 2024; 15(1):41-46.

PMID: 38188545 PMC: 10765082. DOI: 10.5847/wjem.j.1920-8642.2023.084.

Neurologic and Psychiatric Manifestations of Bradykinin-Mediated Angioedema: Old and New Challenges.

Mormile I, Palestra F, Petraroli A, Loffredo S, Rossi F, Spadaro G Int J Mol Sci. 2023; 24(15).

PMID: 37569559 PMC: 10419085. DOI: 10.3390/ijms241512184.

References

Myslimi F, Caparros F, Dequatre-Ponchelle N, Moulin S, Gautier S, Girardie P . Orolingual Angioedema During or After Thrombolysis for Cerebral Ischemia. Stroke. 2016; 47(7):1825-30. DOI: 10.1161/STROKEAHA.116.013334. View

Lin S, Tang S, Tsai L, Yeh S, Hsiao Y, Chen Y . Orolingual angioedema after alteplase therapy of acute ischaemic stroke: incidence and risk of prior angiotensin-converting enzyme inhibitor use. Eur J Neurol. 2014; 21(10):1285-91. DOI: 10.1111/ene.12472. View

Kario K, Wang J . Toward "Zero" Cardiovascular Events in Asia: The HOPE Asia Network. JACC Asia. 2022; 1(1):121-124. PMC: 9627837. DOI: 10.1016/j.jacasi.2021.03.003. View

Batenburg W, Tom B, Schuijt M, Danser A . Angiotensin II type 2 receptor-mediated vasodilation. Focus on bradykinin, NO and endothelium-derived hyperpolarizing factor(s). Vascul Pharmacol. 2005; 42(3):109-18. DOI: 10.1016/j.vph.2005.01.005. View

Engelter S, Fluri F, Buitrago-Tellez C, Marsch S, Steck A, Ruegg S . Life-threatening orolingual angioedema during thrombolysis in acute ischemic stroke. J Neurol. 2005; 252(10):1167-70. DOI: 10.1007/s00415-005-0789-9. View

Rababah J, Al-Hammouri M, AlNsour E . Effectiveness of an educational program on improving healthcare providers' knowledge of acute stroke: A randomized block design study. World J Emerg Med. 2021; 12(2):93-98. PMC: 7947558. DOI: 10.5847/wjem.j.1920-8642.2021.02.002. View

Campbell D, Krum H, Esler M . Losartan increases bradykinin levels in hypertensive humans. Circulation. 2005; 111(3):315-20. DOI: 10.1161/01.CIR.0000153269.07762.3B. View

. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995; 333(24):1581-7. DOI: 10.1056/NEJM199512143332401. View

Wang Y, Li Y, Chen Y, Zhang C, Dong Z, Wang Z . Analysis of related factors of orolingual angioedema after rt-PA intravenous thrombolytic therapy. Eur Rev Med Pharmacol Sci. 2018; 22(5):1478-1484. DOI: 10.26355/eurrev_201803_14496. View

10.

Rudolf J, Grond M, Prince W, Schmulling S, Heiss W . Evidence of anaphylaxy after alteplase infusion. Stroke. 1999; 30(5):1142-3. DOI: 10.1161/01.str.30.5.1142. View

11.

Correia A, Matias G, Calado S, Lourenco A, Viana-Baptista M . Orolingual angiodema associated with alteplase treatment of acute stroke: a reappraisal. J Stroke Cerebrovasc Dis. 2014; 24(1):31-40. DOI: 10.1016/j.jstrokecerebrovasdis.2014.07.045. View

12.

Hill M, Buchan A . Thrombolysis for acute ischemic stroke: results of the Canadian Alteplase for Stroke Effectiveness Study. CMAJ. 2005; 172(10):1307-12. PMC: 557101. DOI: 10.1503/cmaj.1041561. View